Modified Tyr-hGH fragment 177-191 evaluated for lipid metabolic signaling and chondrocyte matrix stimulation without diabetogenic side effects.
Scan vial QR or input synthesis lot number.
C-TERMINAL LIPOLYTIC DOMAIN
Modified Tyr-hGH fragment 177-191 evaluated for lipid metabolic signaling and chondrocyte matrix stimulation without diabetogenic side effects.
LifeNootropics enforces rigorous multi-stage HPLC and MS analytical standards across all synthesized batches. Providing verifiable fidelity to scientific institutions worldwide.
For in-vitro research use only. Not for human consumption.